2000
DOI: 10.3748/wjg.v5.i4.312
|View full text |Cite
|
Sign up to set email alerts
|

A study of the ameliorating effects of carnitine on hepatic steatosis induced by total parenteral nutrition in rats

Abstract: AIM To investigate the effects of carnitine on ameliorating hepatic steatosis induced by total parenteral nutrition (TPN) in animal model. METHODS Eighteen normal Wistar rats and 19 cirrhotic Wistar rats induced by carbon tetrachloride were randomly divided into three groups, i. e., free access to food and drink (group A), TPN (group B) and TPN+carnitine (group C) for one week, respectively. Hepatic function, histology and its fat content were determined on the 7th day. RESULTS Hepatic triglyceride (TG) and ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 8 publications
1
5
0
Order By: Relevance
“…The data herein indicate that l ‐car supplementation of the SRS cocktail was critical for macrosteatotic hepatocyte defatting and improved resistance to H/R stress under hyperoxic (90% O 2 ) conditions. The defatting effect of l ‐car is consistent with studies showing that the administration of l ‐car as a nutritional supplement to dieting patients with nonalcoholic steatohepatitis or to rats with steatotic livers reduced hepatic steatosis and TG levels . Although a large body of literature describes the ability of l ‐car supplementation to promote FFA oxidation, l ‐car may have contributed in other ways to the increase in hepatocyte resistance to H/R stress.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…The data herein indicate that l ‐car supplementation of the SRS cocktail was critical for macrosteatotic hepatocyte defatting and improved resistance to H/R stress under hyperoxic (90% O 2 ) conditions. The defatting effect of l ‐car is consistent with studies showing that the administration of l ‐car as a nutritional supplement to dieting patients with nonalcoholic steatohepatitis or to rats with steatotic livers reduced hepatic steatosis and TG levels . Although a large body of literature describes the ability of l ‐car supplementation to promote FFA oxidation, l ‐car may have contributed in other ways to the increase in hepatocyte resistance to H/R stress.…”
Section: Discussionsupporting
confidence: 81%
“…The defatting effect of L-car is consistent with studies showing that the administration of L-car as a nutritional supplement to dieting patients with nonalcoholic steatohepatitis or to rats with steatotic livers reduced hepatic steatosis and TG levels. 28,29 Although a large body of literature describes the ability of L-car supplementation to promote FFA oxidation, 16,17,19,30 L-car may have contributed in other ways to the increase in hepatocyte resistance to H/R stress. For example, the addition of L-car to a cold preservation solution for 24 hours was reported to increase ATP levels in steatotic rat livers.…”
Section: Discussionmentioning
confidence: 99%
“…Most studies on PepT1 have focused on its fundamental kinetic properties and its functional and structural characterization [19][20][21] . Previous studies have shown that the functions of intestine (including PepT1) were changed under the influence of many factors [22,23] . However, few reports have dealt with the hormonal regulation of PepT1.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, L-carnitine was shown to improve glucose tolerance and insulin sensitivity in animals as well as in healthy and diabetic patients [ 12 , 13 ]. Moreover, L-carnitine supplementation was shown to be useful for the treatment of hepatic steatosis induced by total parenteral nutrition in rodents [ 14 ] and nonalcoholic steatohepatitis in humans [ 15 , 16 ]. Furthermore, L-carnitine was reported to reduce hepatic inflammation and plasma levels of cytokines and acute phase proteins in patients with chronic hepatitis C [ 16 ].…”
Section: Introductionmentioning
confidence: 99%